These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A fortultousness association: Bartter's syndrome and chondrocalcinosis (author's transl)]. Goulon M; Raphael JC; De Rohan P Nouv Presse Med; 1980 Apr; 9(18):1291-5. PubMed ID: 7375363 [TBL] [Abstract][Full Text] [Related]
4. Bartter's syndrome with normal chloride reabsorption during indomethacin treatment. Hornych A; Huet de Barochez Y; Bariéty J; Branca GF; Vigeral P; Girard JF; Kazatchkine M; De Gennes JL; Truffert J; Bocquet L Nephron; 1987; 46(2):137-43. PubMed ID: 3600922 [TBL] [Abstract][Full Text] [Related]
5. Correction of increased prostacyclin production in Bartter's syndrome by indomethacin. Güllner HG; Cerletti C; Bartter FC; Gill JR; Smith JB Trans Assoc Am Physicians; 1980; 93():130-40. PubMed ID: 7018063 [No Abstract] [Full Text] [Related]
8. The role of prostaglandins in Bartter's syndrome. Winterborn MH; Hewitt GJ; Mitchell MD Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882 [TBL] [Abstract][Full Text] [Related]
9. On the pathogenetic role of prostaglandins in Bartter's syndrome. Nielsen I; Hesse B; Christensen P Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandins and aspirin therapy in Bartter's syndrome. Norby L; Flamenbaum W; Lentz R; Ramwell P Lancet; 1976 Sep; 2(7986):604-6. PubMed ID: 61344 [TBL] [Abstract][Full Text] [Related]
11. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139 [TBL] [Abstract][Full Text] [Related]
12. Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Gill JR; Frölich JC; Bowden RE; Taylor AA; Keiser HR; Seyberth HW; Oates JA; Bartter FC Am J Med; 1976 Jul; 61(1):43-51. PubMed ID: 820194 [TBL] [Abstract][Full Text] [Related]
13. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis]. Favre L; Glasson P; Flory ED; Dray F; Vallotton MB Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome. Hsieh BS; Chen WY; Yen TS; Lai MS Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093 [No Abstract] [Full Text] [Related]
15. Extra- and intracellular potassium concentration and prostaglandin production of skin fibroblasts grown from patients with Bartter's syndrome. Barth A; Fanzun C; Lüthy C; Siegrist M; Koegel R; Oetliker O Prostaglandins Leukot Med; 1986 Jan; 21(1):51-60. PubMed ID: 3081913 [TBL] [Abstract][Full Text] [Related]
17. Comparison of prostaglandin production of skin fibroblasts grown from patients with Bartter's syndrome and from age and sex matched controls. Müllner G; Gähwiler T; Lüthy C; Oetliker O; Dillon MJ; Rosa FC Prostaglandins Leukot Med; 1983 May; 11(1):83-93. PubMed ID: 6410415 [TBL] [Abstract][Full Text] [Related]
19. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism? Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H Nephron; 1977; 19(4):200-13. PubMed ID: 917167 [TBL] [Abstract][Full Text] [Related]